Skip to content

A clinical study to evaluate the efficacy of Shigru taila and Kalingadi taila nasa pichu(nasal pack) in the management of Apeenasa w.s.r to Chronic simple rhinitis

An open label double arm randomized comparative clinical study to evaluate the efficacy of Shigru taila and Kalingadi taila nasapichu in the management of Apeenasa wsr to Chronic simple rhinitis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088273
Enrollment
40
Registered
2025-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J310- Chronic rhinitis

Interventions

None listed

Sponsors

Dr S A Srivatsa Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with lakshanas of Apeenasa Subjects with signs and symptoms of Chronic Simple Rhinitis Subjects of either gender

Exclusion criteria

Exclusion criteria: Subjects with atrophic rhinitis, nasal polyps, epistaxis,Benign and malignant nasal and paranasal tumours. Pregnant and lactating mother. Subjects presenting with major systemic diseases that may interfere with the course of treatment.

Design outcomes

Primary

MeasureTime frame
Shigru taila is more beneficial than Kalingadi taila in the management of Apeenasa Timepoint: 40 days

Secondary

MeasureTime frame
NILTimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactDr Hamsaveni V

Sri Kalabyreshwara Swamy Ayurvedic Medical College Hospital & Research Centre Bangalore

vimalbut@gmail.com9900110912

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026